Abstract
Takumi Kodama, Hidetaka Arimura, Yuko Shirakawa, Yagiz Yedekci, Hidetake Yabuuchi, Noriyuki Nagami, Tadamasa Yoshitake, Yoshiyuki Shioyama, Pervin Hurmuz
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer
10.1016/j.ijrobp.2018.11.051 · 2019
Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?
10.1016/j.ijrobp.2009.07.1751 · 2011
Cost-Utility Analysis of Stereotactic Body Radiation Therapy Versus Surgery for Patients With Stage I Non-small Cell Lung Cancer in Japan
10.1016/j.ijrobp.2024.07.2328 · 2025
Stereotactic body radiation therapy for inoperable early stage lung cancer
10.1001/jama.2010.261 · 2010
Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer
10.1001/jamaoncol.2018.1258 · 2018
Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis
10.1016/s1470-2045(12)70242-5 · 2012
Relapse predictability of topological signature on pretreatment planning CT images of stage I non-small cell lung cancer patients before treatment with stereotactic ablative radiotherapy
10.1111/1759-7714.14483 · 2022
Application and limitation of radiomics approach to prognostic prediction for lung stereotactic body radiotherapy using breath-hold CT images with random survival forest: A multi-institutional study
10.1002/mp.14380 · 2020
Unresolved referenced work
2005
Censoring in trials testing immunotherapy in advanced cancers. A systematic review and a meta-research study
2025
Regression-based Proximal Causal Inference for Right-censored Time-to-event Data
10.1097/ede.0000000000001884 · 2025
Sensitivity to censored-at-random assumption in the analysis of time-to-event endpoints
10.1002/pst.1738 · 2016
Imputation methods for informative censoring in survival analysis with time dependent covariates
10.1016/j.cct.2023.107401 · 2024
A Bayesian Approach for Imputation of Censored Survival Data
10.3390/stats5010006 · 2022
Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects
10.1038/s41467-022-28410-9 · 2022
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement
10.1136/bmj.g7594 · 2015
Homological radiomics analysis for prognostic prediction in lung cancer patients
10.1016/j.ejmp.2019.11.026 · 2020
A simulation study of the number of events per variable in logistic regression analysis
10.1016/s0895-4356(96)00236-3 · 1996
Statistical pattern recognition: A review
10.1109/34.824819 · 2000
Multiscale Fusion Models With Genomic, Topological, and Pathomic Features to Predict Response to Radiation Therapy for Non-Small Cell Lung Cancer Patients
10.1016/j.labinv.2025.104204 · 2025
Unresolved referenced work
Kept as external metadata until matched
MRI-Based Digital Models Forecast Patient-Specific Treatment Responses to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
10.1158/0008-5472.can-22-1329 · 2022
Unresolved referenced work
2018
A Weibull multi-state model for the dependence of progression-free survival and overall survival
10.1002/sim.6501 · 2015
A Combined Model to Improve the Prediction of Local Control for Lung Cancer Patients Undergoing Stereotactic Body Radiotherapy Based on Radiomic Signature Plus Clinical and Dosimetric Parameters
10.3389/fonc.2021.819047 · 2022
Prediction of Distant Metastases After Stereotactic Body Radiation Therapy for Early Stage NSCLC: Development and External Validation of a Multi-Institutional Model
10.1016/j.jtho.2022.11.007 · 2023
No additional external references are available.